Home » Topics » Conferences

Conferences
RSS

UR-9825 compared to itraconazole and fluconazole for activity against yeasts

Sep. 28, 1998

Comparative in vitro and in vivo activity of WQ-3034 reported at ICAAC

Sep. 28, 1998

Xoma presents new BPI-related findings and Neuprex phase II data at ICAAC

Sep. 28, 1998

Parasin I: new antimicrobial peptide produced by catfish

Sep. 28, 1998

More new azolylphenyl oxazolidinones in development at P&U

Sep. 28, 1998

Modifications to the linezolid molecule a focus of research at Pharmacia & Upjohn

Sep. 28, 1998

UCB's anticonvulsant drug levetiracetam is safe and effective in phase III trials

Sep. 28, 1998

P&U explores modifications to linezolid; new, more active oxazolidinones result

Sep. 25, 1998

Zanamivir results presented at ICAAC; two more regulatory filings announced

Sep. 25, 1998

In vitro and in vivo activity of S-34109 against Chlamydia and MRSA

Sep. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...